SCHEMBL17488662

SCHEMBL17488662

Cc1nc2c(F)cc(-c3nc(Nc4ccc(C(=O)N5CC6CC5CN6)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.55
CDK2 P24941 18/20 0.55
CDK6 Q00534 17/20 0.55
CDK1 P06493 8/20 0.55
CDK9 P50750 5/20 0.55
CCNB1 P14635 5/20 0.55
CDK7 P50613 4/20 0.55
CCNE1 P24864 4/20 0.55
CCNA2 P20248 3/20 0.55
CCND3 P30281 3/20 0.55
KDR P35968 2/20 0.55
CIT O14578 1/20 0.55
GAK O14976 1/20 0.55
DYRK3 O43781 1/20 0.55
CCNT1 O60563 1/20 0.55
STK16 O75716 1/20 0.55
CCNK O75909 1/20 0.55
STK10 O94804 1/20 0.55
PRKD3 O94806 1/20 0.55
ABCB11 O95342 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488689 0.88 CDK4 (0.56) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17477148 0.86 CDK4 (0.59) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17489232 0.85 CDK4 (0.62) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17489290 0.84 CDK4 (0.59) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17489121 0.84 CDK4 (0.58) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17489245 0.84 CDK4 (0.58) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17477193 0.84 CDK4 (0.62) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17489248 0.84 CDK4 (0.58) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17489215 0.84 CDK4 (0.58) CDK4CDK2CDK6CDK1CDK9
SCHEMBL17488784 0.84 CDK4 (0.59) CDK4CDK2CDK6CDK1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed